As ALOX12 is highly expressed in cancer cells [43–46] and no ALOX12 activator has been reported so far, our study unveiling TPCI-induced ALOX12 activation should broaden the applicability of ferroptosis in cancer therapy. Here, ALOX12 is linked to cancer.